170 related articles for article (PubMed ID: 26676260)
1. An optimized, fast-to-perform mouse lung infection model with the human pathogen Chlamydia trachomatis for in vivo screening of antibiotics, vaccine candidates and modified host-pathogen interactions.
Dutow P; Wask L; Bothe M; Fehlhaber B; Laudeley R; Rheinheimer C; Yang Z; Zhong G; Glage S; Klos A
Pathog Dis; 2016 Mar; 74(2):. PubMed ID: 26676260
[TBL] [Abstract][Full Text] [Related]
2. Differing effects of azithromycin and doxycycline on cytokines in cells from Chlamydia trachomatis-infected women.
Srivastava P; Bhengraj AR; Jha HC; Vardhan H; Jha R; Singh LC; Salhan S; Mittal A
DNA Cell Biol; 2012 Mar; 31(3):392-401. PubMed ID: 21848430
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
[TBL] [Abstract][Full Text] [Related]
4. Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection.
Yang X; Brunham RC
J Immunol; 1998 Aug; 161(3):1439-46. PubMed ID: 9686609
[TBL] [Abstract][Full Text] [Related]
5. Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice.
Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
BMC Infect Dis; 2005 Nov; 5():105. PubMed ID: 16293190
[TBL] [Abstract][Full Text] [Related]
6. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
[TBL] [Abstract][Full Text] [Related]
7. Transcervical Inoculation with Chlamydia trachomatis Induces Infertility in HLA-DR4 Transgenic and Wild-Type Mice.
Pal S; Tifrea DF; Zhong G; de la Maza LM
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29038126
[No Abstract] [Full Text] [Related]
8. Vaccination with MIP or Pgp3 induces cross-serovar protection against chlamydial genital tract infection in mice.
Luan X; Peng B; Li Z; Tang L; Chen C; Chen L; Wu H; Sun Z; Lu C
Immunobiology; 2019 Mar; 224(2):223-230. PubMed ID: 30558842
[TBL] [Abstract][Full Text] [Related]
9.
Lanfermann C; Kohn M; Laudeley R; Rheinheimer C; Klos A
Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34451996
[No Abstract] [Full Text] [Related]
10. Complement C3 opsonization of Chlamydia trachomatis facilitates uptake in human monocytes.
Lausen M; Christiansen G; Karred N; Winther R; Poulsen TBG; Palarasah Y; Birkelund S
Microbes Infect; 2018; 20(6):328-336. PubMed ID: 29729435
[TBL] [Abstract][Full Text] [Related]
11. A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.
Bode J; Dutow P; Sommer K; Janik K; Glage S; Tümmler B; Munder A; Laudeley R; Sachse KW; Klos A
PLoS One; 2012; 7(11):e50327. PubMed ID: 23189195
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Multi-Subunit Vaccine against
Lanfermann C; Wintgens S; Ebensen T; Kohn M; Laudeley R; Schulze K; Rheinheimer C; Hegemann JH; Guzmán CA; Klos A
Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34204170
[No Abstract] [Full Text] [Related]
13. Status of vaccine research and development of vaccines for Chlamydia trachomatis infection.
Poston TB; Gottlieb SL; Darville T
Vaccine; 2019 Nov; 37(50):7289-7294. PubMed ID: 28111145
[TBL] [Abstract][Full Text] [Related]
14.
Faris R; Andersen SE; McCullough A; Gourronc F; Klingelhutz AJ; Weber MM
Front Cell Infect Microbiol; 2019; 9():399. PubMed ID: 32039039
[No Abstract] [Full Text] [Related]
15. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.
Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
J Microbiol Immunol Infect; 2005 Dec; 38(6):383-93. PubMed ID: 16341338
[TBL] [Abstract][Full Text] [Related]
16. Stromal Fibroblasts Drive Host Inflammatory Responses That Are Dependent on Chlamydia trachomatis Strain Type and Likely Influence Disease Outcomes.
Jolly AL; Rau S; Chadha AK; Abdulraheem EA; Dean D
mBio; 2019 Mar; 10(2):. PubMed ID: 30890604
[No Abstract] [Full Text] [Related]
17. Chlamydia trachomatis Is Resistant to Inclusion Ubiquitination and Associated Host Defense in Gamma Interferon-Primed Human Epithelial Cells.
Haldar AK; Piro AS; Finethy R; Espenschied ST; Brown HE; Giebel AM; Frickel EM; Nelson DE; Coers J
mBio; 2016 Dec; 7(6):. PubMed ID: 27965446
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus crispatus mediates anti-inflammatory cytokine interleukin-10 induction in response to Chlamydia trachomatis infection in vitro.
Rizzo A; Fiorentino M; Buommino E; Donnarumma G; Losacco A; Bevilacqua N
Int J Med Microbiol; 2015 Dec; 305(8):815-27. PubMed ID: 26372530
[TBL] [Abstract][Full Text] [Related]
19. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition.
Perry LL; Su H; Feilzer K; Messer R; Hughes S; Whitmire W; Caldwell HD
J Immunol; 1999 Mar; 162(6):3541-8. PubMed ID: 10092812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
